FDA and CDC Lift Pause on Use of the Johnson & Johnson COVID-19 Vaccine: What You Need to Know

The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) recently determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
If you are a healthcare provider administering the vaccine, please review the Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine. It has been revised to include information about the risk of thrombosis-thrombocytopenia syndrome, which has occurred in a very small number of people who have received the Janssen COVID-19 Vaccine.